Incidence and Risk of Hypertension With a Novel Multi-Targeted Kinase Inhibitor Axitinib in Cancer Patients: A Systematic Review and Meta-Analysis
British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.12149
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 20, 2013
Authors
Publisher
Wiley